Start an analysis for MDT
Medtronic plc
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $5.0bn | 31-Jul-26 | 10-Q filed 03-Sep-26 |
| Remaining authorization | $958m | 31-Jul-26 | 10-Q filed 03-Sep-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $226m | 31-Jul-26 | 10-Q filed 03-Sep-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $5.0bn | $958m | n/a | In March 2024, the Company's Board of Directors authorized the repurchase of $5.0 billion of the Company's ordinary shares. There is no specific time period associated with these repurchase authorizations.10-Q filed 03-Sep-26 |
Open-market repurchases
- May ’26
- Jul ’26
- Jul ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 31-Jul-26 | 1,017,165 | $83.24 | $85m | 10-Q filed 03-Sep-26 |
| 03-Jul-26 | 1,246,200 | $80.54 | $100m | 10-Q filed 03-Sep-26 |
| 29-May-26 | 502,144 | $80.67 | $41m | 10-Q filed 03-Sep-26 |